{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:26:17Z","timestamp":1792513577369,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports\u00ae"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ekir.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T02:49:52Z","timestamp":1704941392000},"page":"863-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS"],"prefix":"10.1016","volume":"9","author":[{"given":"Suguru","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne Skou","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Komaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-018-1056-5","article-title":"Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Yamamoto","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00198-019-05187-0","article-title":"The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone","volume":"31","author":"Jansz","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib8","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfz060","article-title":"Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort","volume":"35","author":"Lamina","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ekir.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3390\/nu14102124","article-title":"Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease","volume":"14","author":"Haarhaus","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0896860820918131","article-title":"High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients","volume":"41","author":"Chen","year":"2021","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5414\/CNP74091","article-title":"Serum alkaline phosphatase and mortality in hemodialysis patients","volume":"74","author":"Beddhu","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13387-z","article-title":"Elevated serum alkaline phosphatase and cardiovascular or all-cause mortality risk in dialysis patients: a meta-analysis","volume":"7","author":"Fan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2215\/CJN.08621209","article-title":"Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization","volume":"5","author":"Abramowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 suppl 2","key":"10.1016\/j.ekir.2024.01.002_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS):an international hemodialysis study","volume":"57","author":"DAG","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib21","doi-asserted-by":"crossref","first-page":"e4350","DOI":"10.1210\/clinem\/dgac522","article-title":"Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients on hemodialysis","volume":"107","author":"Evenepoel","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4097\/kja.20137","article-title":"Data transformation: a focus on the interpretation","volume":"73","author":"Lee","year":"2020","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.ekir.2024.01.002_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/aje\/kwf110","article-title":"Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men","volume":"156","author":"Taylor","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ekir.2024.01.002_bib25","series-title":"Statistical Analysis With Missing Data","author":"Little","year":"1987"},{"key":"10.1016\/j.ekir.2024.01.002_bib26","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A\u00a0higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients","volume":"4","author":"Shantouf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000494924","article-title":"Factors and outcome of renal osteodystrophy-associated initial fragility fracture in end-stage renal disease patients","volume":"5","author":"Li","year":"2019","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.ekir.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.ackd.2019.09.006","article-title":"Bone-vascular axis in chronic kidney disease","volume":"26","author":"Evenepoel","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000151769","article-title":"Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study","volume":"29","author":"Coen","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115699","article-title":"Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease","volume":"143","author":"Salam","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000355807","article-title":"Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients","volume":"39","author":"Ishimura","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ekir.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1681\/ASN.2014070686","article-title":"High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis","volume":"26","author":"Malluche","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-41-2-339","article-title":"Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism","volume":"41","author":"Llach","year":"1975","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2024.01.002_bib39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"Jorgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.002_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.002_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ekir.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ekir.2024.01.002_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.kint.2018.09.018","article-title":"A\u00a0distinct bone phenotype in ADPKD patients with end-stage renal disease","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","article-title":"Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration","volume":"95","author":"Diaz-Tocados","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.kint.2020.04.013","article-title":"Clinical evidence of direct bone effects of Cinacalcet","volume":"98","author":"Jorgensen","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.002_bib46","first-page":"449","article-title":"Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency. Article in Spanish","volume":"19","author":"Sanchez Navarro","year":"2002","journal-title":"An Med Int"}],"container-title":["Kidney International Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:28:51Z","timestamp":1766449731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2468024924000020"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.01.002","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports\u00ae","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}